PeproTech Cytokine Production Facility
Expansion Of Our Facility
PeproTech is proud to share a pivotal moment of growth in our history that, we believe, will help us make an even greater impact on the scientific community. As of November 2020, we’ve relocated from Rocky Hill, NJ to a state-of-the-art, 65,000 square foot facility in Cranbury, NJ. This $30 million investment allows us to house our New Jersey employees and corporate headquarters under one roof, while continuing to offer customers unrivalled products and support for the research and cellular therapy markets. As you explore new technologies, we’ll be by your side at the forefront of research, ready to grow in our new facility at pace with our ever-evolving industry.
With significantly more square footage for GMP cleanrooms, we will be able to support the manufacture of not only bacterial expressed GMP products, but cell culture derived GMP products. The relocation has also allowed us to double, and in some cases triple, our production of high-quality research products. These advancements will have a transformative effect on our ability to meet your emerging needs, as well as the needs of the greater cellular, gene therapy and life science markets.
While we’re excited to continue growing on a global scale, we remain steadfast in our commitment to providing the personalized support you would expect from a trusted partner.
Your success is our top priority.
Please contact us if you would like further information:
Email: slovell@peprotech.co.uk
Tel: 020 7610 3062
